Sex Differences in Cardiovascular Effectiveness of Newer Glucose‐Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sex Differences in Cardiovascular Effectiveness of Newer Glucose‐Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus
Authors
Keywords
-
Journal
Journal of the American Heart Association
Volume 9, Issue 1, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2020-01-04
DOI
10.1161/jaha.119.012940
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Empagliflozin on Left Ventricular Mass in Patients with Type 2 Diabetes and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial
- (2019) Subodh Verma et al. CIRCULATION
- Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
- (2018) Emelia J. Benjamin et al. CIRCULATION
- Cardiovascular Effects of New Oral Glucose-Lowering Agents
- (2018) André J. Scheen CIRCULATION RESEARCH
- Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes
- (2018) Sean L. Zheng et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Participation of Women in Clinical Trials
- (2018) Louise Pilote et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular Drugs
- (2018) Pamela E. Scott et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Antihyperglycemic Therapies to Treat Patients With Heart Failure and Diabetes Mellitus
- (2018) Abhinav Sharma et al. JACC-Heart Failure
- Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2018) Melanie J. Davies et al. DIABETOLOGIA
- The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction
- (2018) Jonathan D. Newman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2018) Thomas A Zelniker et al. LANCET
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
- (2018) Adrian F Hernandez et al. LANCET
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sex and gender landscape in pharmacology
- (2017) Flavia Franconi et al. PHARMACOLOGICAL RESEARCH
- Sex-gender-related therapeutic approaches for cardiovascular complications associated with diabetes
- (2017) Ilaria Campesi et al. PHARMACOLOGICAL RESEARCH
- Effect of Long-term Incretin-Based Therapies on Ischemic Heart Diseases in Patients with Type 2 Diabetes Mellitus: A Network Meta-analysis
- (2017) Che-Yi Chou et al. Scientific Reports
- Cardiovascular Outcomes and Risks After Initiation of a Sodium Glucose Cotransporter 2 Inhibitor
- (2017) Jacob A. Udell et al. CIRCULATION
- Glucagon-Like Peptide 1 Receptor Activation Attenuates Platelet Aggregation and Thrombosis
- (2016) Alison Cameron-Vendrig et al. DIABETES
- Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
- (2016) Alexandra Kautzky-Willer et al. ENDOCRINE REVIEWS
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sex and estrogens alter the action of glucagon-like peptide-1 on reward
- (2016) Jennifer E. Richard et al. Biology of Sex Differences
- Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus
- (2015) Shuo-Ming Ou et al. ANNALS OF INTERNAL MEDICINE
- Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus
- (2015) Judith G. Regensteiner et al. CIRCULATION
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
- (2015) Jennifer B. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- Conditions for confounding of interactions
- (2015) Aihua Liu et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events
- (2014) Sanne A. E. Peters et al. DIABETOLOGIA
- Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775 385 individuals and 12 539 strokes
- (2014) Sanne A E Peters et al. LANCET
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evidence of subgroup-specific treatment effect in the absence of an overall effect: is there really a contradiction?
- (2013) Michal Abrahamowicz et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Improved Outcomes in Heart Failure Treated With High-Dose ACE Inhibitors and ARBs: A Population-Based Study
- (2012) Giordano Egiziano et al. ARCHIVES OF INTERNAL MEDICINE
- Case Definitions for Acute Myocardial Infarction in Administrative Databases and Their Impact on In-Hospital Mortality Rates
- (2012) Amy Metcalfe et al. HEALTH SERVICES RESEARCH
- Platelet Biology and Response to Antiplatelet Therapy in Women
- (2012) Tracy Y. Wang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Administrative data have high variation in validity for recording heart failure
- (2011) Susan Quach et al. CANADIAN JOURNAL OF CARDIOLOGY
- Patient Factors Associated with Glucagonlike Peptide 1 Receptor Agonist use with and without Insulin
- (2011) Irl Hirsch et al. Endocrine Practice
- Adverse effects in women: implications for drug development and regulatory policies
- (2011) Ameeta Parekh et al. Expert Review of Clinical Pharmacology
- Differences in baseline characteristics between patients prescribed sitagliptin versus exenatide based on a US electronic medical record database
- (2010) Qiaoyi Zhang et al. ADVANCES IN THERAPY
- Hospital Admissions for Acute Myocardial Infarction, Angina, Stroke, and Asthma After Implementation of Arizona's Comprehensive Statewide Smoking Ban
- (2010) Patricia M. Herman et al. AMERICAN JOURNAL OF PUBLIC HEALTH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started